Instrument Inactif

Communiqués MEDIGUSADR Nasdaq

Actions

24/11/17	Medigus : Announces Third Quarter 2017 Financial Results	MW
24/11/17	MEDIGUSADR : Medigus Announces Pricing of $1.6 Million Registered Direct	MW
17/10/17	Medigus : Receives First Purchase Order From Izasa Hospital in Spain for Its MUSE System	MW
18/09/17	Medigus : Announces Second Quarter 2017 Financial Results	MW
26/07/17	Medigus : Broadens Availability of MUSE(TM) Through Distribution Agreement With ADMEDICS AG in Switzerland and Liechtenstein	MW
19/07/17	Medigus : Expands Global Commercial Availability of MUSE Through Distribution Agreement With Izasa Hospital, S.L.U. in Spain	MW
18/07/17	Medigus : and Golden Grand Expand Distribution Arrangement in China for $27M of MUSE Systems	MW
30/05/17	Medigus : Announces First Quarter 2017 Financial Results	MW
15/05/17	MEDIGUSADR : Medigus Announces Japanese and European Patents for micro ScoutCam(TM) Microvisual Technology	MW
09/05/17	Medigus : Presents New Data Demonstrating the MUSE(TM) System Improves GERD Symptoms and Reduces Proton Pump Inhibitor Reliance	MW
04/05/17	MEDIGUSADR : New Data on the MUSE System to Be Presented During Digestive Disease Week(TM) (DDW) 2017	MW
27/04/17	MEDIGUSADR : First Ten MUSE(TM) Procedures for GERD Performed in China as Part of CFDA Multi-Center Clinical Study	MW
04/04/17	Medigus : Regains Compliance With The Nasdaq Listing Requirements	MW
31/03/17	Medigus : Announces Availability of Annual Report on Form 20-F	MW
24/03/17	Medigus : Announces $7.5 Million Public Offering	MW